Asia Pacific Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Country Forecast 2020-2031

Asia Pacific Swine Vaccines Market size was valued at US$ 838.3 million in 2024 and is expected to reach US$ 1,203.4 million by 2031, growing at a significant CAGR of 5.3% from 2025-2031. Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.Swine production is vital to global food security, agricultural countries, and domestic and international trade. Contagious diseases have a global impact on pig health, as well as the swine industry's stability and production. As a result, increased swine disease prevalence is expected to boost the market in the coming years. Porcine Parvovirus (PPV) is a reproductive illness seen in nearly all pig farms across the world. PRRS (Porcine Reproductive and Respiratory Syndrome) is still a common disease in pig farms, causing financial losses due to its negative effects on reproduction and growth, as well as clinical sickness.